Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$47.58
+2.7%
$47.69
$33.78
$69.56
$52.34M1.6312,713 shs4,145 shs
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
$21.30
+1.4%
$21.09
$17.84
$24.84
$38.55M0.6116,789 shs3,828 shs
LFSC
F/m Emerald Life Sciences Innovation ETF
$23.55
+1.6%
$22.21
$18.78
$27.76
$52.75MN/A3,465 shs2,564 shs
MEDX
Horizon Kinetics Medical ETF
$26.93
+2.4%
$26.91
$23.46
$32.00
$15.89M0.911,094 shs1,297 shs

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
+2.74%+6.66%+0.68%-14.47%-9.51%
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
+1.38%+3.30%+1.57%-5.79%+0.05%
LFSC
F/m Emerald Life Sciences Innovation ETF
+1.95%+5.26%+4.07%-10.05%+2,354,999,900.00%
MEDX
Horizon Kinetics Medical ETF
+2.36%+2.28%-0.07%-1.77%-4.50%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/A
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
N/AN/AN/AN/AN/AN/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/AN/AN/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
2.74
Moderate Buy$47.58N/A
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
2.74
Moderate Buy$21.30N/A
LFSC
F/m Emerald Life Sciences Innovation ETF
2.94
Moderate Buy$23.55N/A
MEDX
Horizon Kinetics Medical ETF
2.68
Moderate Buy$26.93N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/A
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
N/AN/AN/AN/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/A21.19N/AN/AN/AN/AN/A
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
N/AN/A24.43N/AN/AN/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/A0.00N/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/A24.42N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$0.941.98%N/AN/AN/A
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
$0.241.13%N/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
$0.501.86%N/AN/AN/A

Latest BIB, LFSC, IBBQ, and MEDX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/25/2025
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
Quarterly$0.13091.03%3/26/20253/26/20254/1/2025
3/24/2025
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
$0.04023/24/20253/24/20253/28/2025
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/A1.10 millionN/AOptionable
Invesco Nasdaq Biotechnology ETF stock logo
IBBQ
Invesco Nasdaq Biotechnology ETF
N/A1.81 millionN/AOptionable
LFSC
F/m Emerald Life Sciences Innovation ETF
N/A2.24 millionN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/A590,000N/ANot Optionable

Media Sentiment Over Time

ProShares Ultra Nasdaq Biotechnology stock logo

ProShares Ultra Nasdaq Biotechnology NASDAQ:BIB

$47.58 +1.27 (+2.74%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$47.54 -0.03 (-0.07%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Invesco Nasdaq Biotechnology ETF stock logo

Invesco Nasdaq Biotechnology ETF NASDAQ:IBBQ

$21.30 +0.29 (+1.38%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$21.28 -0.02 (-0.09%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.

F/m Emerald Life Sciences Innovation ETF NASDAQ:LFSC

$23.55 +0.37 (+1.60%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$23.45 -0.10 (-0.42%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

Horizon Kinetics Medical ETF NASDAQ:MEDX

$26.93 +0.62 (+2.36%)
Closing price 05/2/2025 03:50 PM Eastern
Extended Trading
$27.12 +0.19 (+0.71%)
As of 05/2/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics.